Abstract
The mammalian Toll-like receptors (TLRs) were first recognized as innate immune sensors when it was discovered that TLR4 is the key component of the mammalian endotoxin (lipopolysaccharide; LPS) receptor. This determination was made when a spontaneous mouse mutation, Lps, was positionally cloned and found to reside with the Tlr4 locus. In all, we now know of the existence of eleven mouse TLRs and ten human TLRs, which collectively serve as the principal sensors of the innate immune system. Without them, small inocula of microorganisms would pose a major threat to the host, growing unchecked for a long period of time before they are recognized. These TLRs are served by a collection of at least five adapter proteins, each with homology to the TLRs themselves, permitting homotypic interaction to occur. Since a pure forward genetic approach led to the identification of the LPS receptor, ENU mutagenesis has been applied to the identification of other critical components of TLR signaling pathways. This approach has revealed that one of the adapter proteins, Lps2 (also known as Trif or Ticam-1) is required for normal responses to double-stranded RNA and LPS. It now appears that two and only two branches of the LPS sensing pathway exist downstream of TLR4 in macrophages: one dependent upon the joint function of the adapter proteins MyD88 and MAL/Tirap; the other dependent upon Lps2. Poly I:C sensing, on the other hand, has but one recognizable branch, leading to type I interferon induction. Lps2 is an indispensable component of this branch. Destructive mutations affecting Lps2 cause resistance to LPS toxicity, but also, heightened susceptibility to infection by mouse cytomegalovirus (mCMV). Lps2 is therefore the most proximal component of a signal integration system required for innate immune responses to both viral and bacterial infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085–2088.
Beutler B, Rietschel ET. Timeline: Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003; 3(2): 169–176.
Pfeiffer R. Untersuchungen tiber das Choleragift. Z Hygiene 1892; 11:393–412.
Heppner G, Weiss DW. High susceptibility of strain A mice to endotoxin and endotoxin red blood cell mixtures. J Bacteriol 1965; 90:696–703.
Coutinho A, Meo T. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 1978; 7:17–24.
Watson J, Kelly K, Largen M et al. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol 1978; 120:422–424.
O’Brien AD, Rosenstreich DL, Scher I et al. Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene. J Immunol 1980; 124:20–24.
Rosenstreich DL, Weinblatt AC, O’Brien AD. Genetic control of resistance to infection in mice. CRC Crit Rev Immunol 1982; 3:263–330.
Moore RN, Goodrum KJ, Berry LJ. Mediation of an endotoxic effect by macrophages. J Reticuloendothel Soc 1976; 19(3):187–197.
Michalek SM, Moore RN, McGhee JR et al. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J Infec Dis 1980; 141:55–63.
Beutler B, Mahoney J, Le Trang N et al. Purification of cachectin, a lipoprotein lipase suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161:984–995.
Beutler B, Greenwald D, Hulmes JD et al. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 1985; 316:552–554.
Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 1985; 229:869–871.
Wright SD, Ramos RA, Tobias PS et al. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431–1433.
Haziot A, Ferrero E, Kontgen F et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CDl4-deficient mice. Immunity 1996; 4(4):407–414.
Poltorak A, Smirnova I, He XL et al. Genetic and physical mapping of the Lps locus-identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Molecules & Diseases 1998; 24(17):340–355.
Nomura N, Miyajima N, Sazuka T et al. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res 1994; 1(1):27–35.
Taguchi T, Mitcham JL, Dower SK et al. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4pl4. Genomics 1996; 32(3):486–488.
Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388(6640):394–397.
Chaudhary PM, Ferguson C, Nguyen V et al. Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood 1998; 91(11):4020–4027.
Rock FL, Hardiman G, Timans JC et al. A family of human receptors structurally related to Drosophila Toll. Proc Nad Acad Sci USA 1998; 95(2):588–593.
Lemaitre B, Nicolas E, Michaut L et al. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86(6):973–983.
Takeuchi O, Kawai T, Sanjo H et al. TLR6: A novel member of an expanding Toll-like receptor family. Gene 1999; 231(1–2):59–65.
Du X, Poltorak A, Wei Y et al. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000; 11(3):362–371.
Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 2000; 11(3):372–378.
Chuang T, Ulevitch RJ. Identification of hTLRlO: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001; 1518(1–2): 157–161.
Janeway CA, Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunology Today 1992; 13(1):11–16.
Anderson KV, Bokla L, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 1985; 42(3):791–798.
Rutschmann S, Kilinc A, Ferrandon D. Cutting edge: the toll pathway is required for resistance to gram-positive bacterial infections in Drosophila. J Immunol 2002; 168(4): 1542–1546.
Gottar M, Gobert V, Michel T et al. The Drosophila immune response against Gram negative bacteria is mediated by a peptidoglycan recognition protein. Nature 2002; 4l6(640):644.
Levashina EA, Langley E, Green C et al. Constitutive activation of toll-mediated antifungal defense in serpin-deficient Drosophila. Science 1999; 285(5435):1917–1919.
Ligoxygakis P, Pelte N, Hoffmann JA et al. Activation of Drosophila Toll during fungal infection by a blood serine protease. Science 2002; 297(5578):114–116.
Poltorak A, Ricciardi-Castagnoli P, Citterio A et al. Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc Natl Acad Sci, USA 2000; 97(5):2163–2167.
Lien E, Means TK, Heine H et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105(4):497–504.
Akashi S, Nagai Y, Ogata H et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13(12):1595–1599.
da Silva CJ, Soldau K, Christen U et al. Lipopolysaccharide is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex: Transfer from CD 14 to TLR4 and MD-2. J Biol Chem 2001; 276(24):21129–21135.
Bauer S, Kirschning CJ, Hacker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98(16):9237–9242.
Mizel SB, West AP, Hantgan RR. Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem 2003; 278: 23624–23629.
Schneider DS, Hudson KL, Lin TY et al. Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev 1991; 5(5):797–807.
Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000; 97(25):13766–13771.
Du X, Poltorak A, Silva M et al. Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor. Blood Cells Molecules & Diseases 1999; 25(21):328–338.
Hultmark D. Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem Biophys Res Commun 1994; 199(1): 144–146.
Adachi O, Kawai T, Takeda K et al. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 1998; 9(1):143–150.
Kawai T, Adachi O, Ogawa T, et al. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1998; 11:115–122.
Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443–451.
Hacker H, Vabulas RM, Takeuchi O et al. Immune Cell Activation by Bacterial CpG-DNA through Myeloid Differentiation Marker 88 and Tumor Necrosis Factor Receptor-Associated Factor (TRAF)6. J Exp Med 2000; 192(4):595–600.
Akira S. Toll-like receptors: Lessons from knockout mice. Biochem Soc Transact 2000; 28(5):551–556.
Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al. Mai (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 4l3(6851):78–83.
Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2(9):835–841.
Horng T, Barton GM, Flavell RA et al. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002; 420(6913):329–333.
Yamamoto M, Sato S, Hemmi H et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002; 420(6913):324–329.
Suzuki N, Suzuki S, Duncan GS et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002; 4l6(6882):750–756.
Lomaga MA, Yeh WC, Sarosi I et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13(8):1015–1024.
Lee J, Mira-Arbibe L, Ulevitch RJ. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J Leukoc Biol 2000; 68(6):909–915.
Kawai T, Takeuchi O, Fujita T et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 2001; 167(10):5887–5894.
Hoshino K, Kaisho T, Iwabe T et al. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 2002; 14(10): 1225–1231.
Hoebe K, Du X, Goode J et al. Lps2: A new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening. J Endotoxin Res 2003; 9(4):250–255.
Yamamoto M, Sato S, Mori K et al. Cutting edge: a novel Toll/IL-1 receptor domain containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169(12):6668–6672.
Oshiumi H, Matsumoto M, Funami K et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003; 4:161–171.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2005 Eurekah.com and Kluwer Academic / Plenum Publishers
About this chapter
Cite this chapter
Beutler, B., Hoebe, K., Georgel, P., Du, X. (2005). Forward Genetic Analysis of TLR Pathways. In: Toll and Toll-Like Receptors: An Immunologic Perspective. Molecular Biology Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-27445-6_9
Download citation
DOI: https://doi.org/10.1007/0-387-27445-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48237-3
Online ISBN: 978-0-387-27445-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)